Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,700 shares, an increase of 1,600.0% from the February 28th total of 100 shares. Based on an average daily trading volume, of 27,500 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are sold short.
Novozymes A/S Stock Performance
Shares of Novozymes A/S stock opened at $57.73 on Friday. The stock has a 50 day moving average of $57.89 and a 200 day moving average of $60.58. The firm has a market capitalization of $27.03 billion, a price-to-earnings ratio of 36.54, a PEG ratio of 3.87 and a beta of 0.91. Novozymes A/S has a fifty-two week low of $52.96 and a fifty-two week high of $72.50.
Novozymes A/S Increases Dividend
The firm also recently declared a dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Monday, April 7th will be issued a dividend of $0.3758 per share. The ex-dividend date of this dividend is Monday, April 7th. This is a boost from Novozymes A/S’s previous dividend of $0.17. Novozymes A/S’s dividend payout ratio is currently 94.94%.
About Novozymes A/S
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Featured Stories
- Five stocks we like better than Novozymes A/S
- How to Use the MarketBeat Dividend Calculator
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- Health Care Stocks Explained: Why You Might Want to Invest
- Top 3 Beverage Stocks Pouring Out Profits
- What Are Growth Stocks and Investing in Them
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.